Mahta Intl.sp. z o.o.

Other professional, scientific and technical activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-06-09
Share capital
5,000.00 PLN
Average employment (people)
3 (2025)
Activity description

Mahta Intl. provides Market Access, HEOR and HTA services, including HTA analyses, pharmacoeconomic studies and reimbursement consulting for pharmaceutical and medical companies. The company supports the launch of therapies in Poland and international markets, delivering reimbursement processes, international projects and publications on topics including pasireotide, pegvisomant, linzagolix and endometriosis.

Registered address
ul. Modra 90/111, 02-661 Warszawa, Poland
Website
Phone
Social media
Electronic delivery address
AE:PL-92298-40717-WICTE-20

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$4,599
Profit allocationDividend
Foreign sales63.03% of revenue ($693,049)
Contingent liabilitiesYes

Filing timeliness

Financial statements were filed on time, on average 129 days early.

  • 202530/03/2026
  • 202407/03/2025
  • 202309/02/2024
  • 202217/03/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Warszawa15,577 / 56,958
Top 27%
Voivodeship · Mazowieckie21,821 / 77,118
Top 28%
Country · Poland86,331 / 297,873
Top 29%

Results vs industry

Revenue
This companyUSD 1.10mMedianUSD 69.67kAverageUSD 515.81k
Net profit
This companyUSD 39.41kMedianUSD 2.54kAverageUSD 5.46k
Operating costs
This companyUSD 1.06mMedianUSD 57.09kAverageUSD 446.59k
Assets
This companyUSD 468.43kMedianUSD 60.97kAverageUSD 1.39m

Offer

  • Market access consulting
  • HTA analyses
  • Pharmacoeconomic analyses
  • Reimbursement strategies
  • Pricing strategies
  • Health outcomes research
  • Evidence synthesis

Website technology

Website
  • Next.js
Analytics and marketing
  • Google Tag Manager

Authorized Representatives

Cezary Tomasz Pruszko – Management Board Member
Michał Filip Jachimowicz – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2022-06-15.

  • mBank
    22 1140 2004 0000 3202 8250 4318
  • mBank
    06 1140 2004 0000 3812 1603 9490

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
LNI Swissgas Eesp. z o.o.
4technologysp. z o.o.
Seagull Forwardingsp. z o.o.
HRE Trustsp. z o.o.
Tomalexsp. z o.o.
Ekodialog Maciej MikulskiS.K.A.
MBR Consultingsp. z o.o.
NAU Music Talents Agencysp. z o.o.
Fair Value Accountingsp. z o.o.
Friisberg Poland Rudzińska Serwińskasp. j.

FAQ

Last updated: 2026-10-07